The rise of copyright’s blockbuster initially drove a period of growth for pharma, nevertheless recent shifts present a murky picture for shareholders. Generic versions are eroding revenue, and persistent legal https://asiyakdft061972.livebloggs.com/47949790/the-blue-pill-and-the-pharmaceutical-industry-a-risky-play